Korro Bio, Inc.
KRROBiotechnology
$14.32+0.81%As of Oct 30vs prior close
- Market cap
- $210.8M
- P/E (TTM)
- –
- From 52W high
- −65.01%
- EPS (LTM)
- -$10.01
- Revenue (LTM)
- $2.4M
- Net margin
- -4477.08%
- Dividend yield
- 0.00%
Nomior Score
20
Emerging BreakoutSpeculativeBottom 7% of the scored universe
Growth—
Quality30
Value39
Momentum21
Resilience27
Growth
−22.26%revenue a year over 6 fiscal years
YE19 $28.9MLTM $2.4M
Connections
Revenue to profitQ4 YE25
The operating loss was 3901% of revenue, wider by 2886 pts on a year.
Who owns it
2funds